A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis.Shigeji Matsubara, Leland W.K. Chung, Haiyen E. Zhau et al.|PubMed|2001Cited by 149
Phase I Dose Escalation Clinical Trial of Adenovirus Vector Carrying Osteocalcin Promoter-Driven Herpes Simplex Virus Thymidine Kinase in Localized and Metastatic Hormone-Refractory Prostate CancerHiroyuki Kubo, Leland W.K. Chung, Thomas A. Gardner et al.|Human Gene Therapy|2003Cited by 127
New targets for therapy in prostate cancer: modulation of stromal–epithelial interactionsLeland W.K. Chung, Haiyen E. Zhau, Shigeji Matsubara et al.|Urology|2003Cited by 55